GSC The List

Post Reply
Forum Home > OEA / OLEOYLETHANOLAMIDE > 2010-2014

[email protected]
Site Owner
Posts: 1174


The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. (full – 2010)

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full – 2010)

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. (full – 2010)

Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women (full – 2010)

Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma (full – 2010)

CD36 gene deletion decreases oleoylethanolamide levels in small intestine of freefeeding mice. (full – 2010)

N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy (full – 2010)

Endocannabinoids and Human Sperm Cells (link to PDF – 2010)

Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. (abst – 2010)

Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice. (abst – 2010)

Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation. (abst – 2010)

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-specific role of oleoylethanolamide. (abst – 2010)

From surface to nuclear receptors: the endocannabinoid family extends its assets. (abst – 2010)

Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. (full – 2011)

Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. (full – 2011)

Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice (full – 2011)

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice (full – 2011)

Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst – 2011)

Gut fat sensing in the negative feedback control of energy balance--recent advances. (abst – 2011)

The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012)

The endocannabinoid system: an overview (full – 2012)

Dynamic changes to the endocannabinoid system in models of chronic pain (full – 2012)

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full – 2012)

The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (full – 2012)

Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012)

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. (full – 2012)

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fearconditioned analgesia and controls fear expression in the presence of nociceptive tone (full – 2012)

G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012)

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full – 2012)

Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full – 2012)

The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area. (full – 2012)

Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. (full – 2012)

Temporal changes in N-acylethanolamine content and metabolism throughout the periadolescent period (full – 2012)

Stimulating beta cell replication and improving islet graft function by GPR119 agonists. (full – 2012)

Synthesis of oleoylethanolamide using lipase. (abst – 2012)

Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α. (abst – 2012)

Optimized synthesis and characterization of N-acylethanolamines and Oacylethanolamines, important family of lipid-signalling molecules. (abst – 2012)

Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder. (full – 2013)

Anandamide Levels Fluctuate in the Bovine Oviduct during the Oestrous Cycle. (full – 2013)

Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full – 2013)

Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full – 2013)

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. (full – 2013)

Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full – 2013)

Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice. (full – 2013)

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (full – 2013)

The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013)

Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study. (full – 2013)

Endocannabinoid and Cannabinoid-Like Fatty Acid Amide Levels Correlate with Pain- Related Symptoms in Patients with IBS-D and IBS-C: A Pilot Study. (full – 2013)

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. (full – 2013)

Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity. (full – 2013)

Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF – 2013)

Biosynthetic Pathways of Bioactive N-Acylethanolamines in Brain (link to PDF – 2013)

Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. (abst – 2013)

Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals. (abst – 2013)

Alterations in the endocannabinoid system in the rat valproic acid model of autism. (abst – 2013)

Detection of the endocannabinoid metabolome in human plasma and breast milk (abst – 2013)

Quantification of endocannabinoids in postmortem brain of schizophrenic subjects. (abst – 2013)

Analysis of the "endocannabinoidome" in peripheral tissues of obese Zucker rats. (abst – 2013)

Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. (abst – 2013)

Exogenous Delta9-Tetrahydrocannabinol Influences Circulating Endogenous Cannabinoids in Humans. (abst – 2013)

The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. (abst – 2013)

Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. (abst – 2013)

Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum. (abst – 2013)

The endocannabinoid system mediates aerobic exercise-induced antinociception in rats. (abst – 2013)

Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease. (abst – 2013)

Brain Region-Specific Changes in N-Acylethanolamine Contents with Time of Day. (abst – 2013)

Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats. (abst – 2013)

The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy. (abst – 2013)

Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full – 2014)

Antidepressants and Changes in Concentration of Endocannabinoids and Nacylethanolamines in Rat Brain Structures. (full – 2014)

Vascular targets for cannabinoids: animal and human studies. (full – 2014)

Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full – 2014)

A role for oleoylethanolamide in chronic lymphocytic leukemia (full – 2014)

Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full – 2014)

Classical endocannabinoid-like compounds and their regulation by nutrients (abst – 2014)

Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. (abst – 2014)

New players in the fatty acyl ethanolamide metabolism. (abst – 2014)

Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. (abst – 2014)

Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. (abst – 2014)

Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst – 2014)

The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst – 2014)

September 30, 2014 at 9:19 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.